SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001398432-21-000029
Filing Date
2021-04-05
Accepted
2021-04-05 15:10:47
Documents
85
Period of Report
2019-03-31

Document Format Files

Seq Description Document Type Size
1 a14262.htm 10-Q 563555
2 NUTRA PHARMA CORP. exh31_1.htm EX-31.1 10193
3 exh32_1.htm EX-32.1 4814
  Complete submission text file 0001398432-21-000029.txt   6602032

Data Files

Seq Description Document Type Size
4 XBRL CALCULATION FILE nphc-20190331_cal.xml EX-101.CAL 42549
5 XBRL DEFINITION FILE nphc-20190331_def.xml EX-101.DEF 408992
6 XBRL LABEL FILE nphc-20190331_lab.xml EX-101.LAB 633134
7 XBRL PRESENTATION FILE nphc-20190331_pre.xml EX-101.PRE 415751
8 XBRL INSTANCE FILE nphc-20190331.xml EX-101.INS 995142
9 XBRL SCHEMA FILE nphc-20190331.xsd EX-101.SCH 91642
Mailing Address 12538 W. ATLANTIC BLVD. CORAL SPRINGS FL 33071
Business Address 12538 W. ATLANTIC BLVD. CORAL SPRINGS FL 33071 (954) 509-0911
NUTRA PHARMA CORP (Filer) CIK: 0001119643 (see all company filings)

IRS No.: 912021600 | State of Incorp.: CA | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 000-32141 | Film No.: 21805034
SIC: 2833 Medicinal Chemicals & Botanical Products